Department of Internal Medicine, Section on Hospital Medicine, Medical College of Wisconsin, Wauwatosa, WI, United States of America.
Lillehei Heart Institute and Cardiovascular Division, University of Minnesota Medical School, Minneapolis, United States of America.
Int J Cardiol. 2023 Jul 15;383:102-109. doi: 10.1016/j.ijcard.2023.04.036. Epub 2023 Apr 24.
The objective of the study was to examine the joint associations of albuminuria and electrocardiographic left atrial abnormality (ECG-LAA) with incident atrial fibrillation (AF) and whether this relationship varies by race.
This analysis included 6670 participants free of clinical cardiovascular disease (CVD), including atrial fibrillation (AF), from the Multi-Ethnic Study of Atherosclerosis. ECG-LAA was defined as P-wave terminal force in V1 [PTFV1] >5000 μV × ms. Albuminuria was defined as urine albumin-creatinine ratio (UACR) ≥30 mg/g. Incident AF events through 2015 were ascertained from hospital discharge records and study-scheduled electrocardiograms. Cox proportional hazard models were used to examine the association of "no albuminuria + no ECG-LAA (reference)", "isolated albuminuria", "isolated ECG-LAA" and "albuminuria + ECG-LAA" with incident AF.
Over a median follow-up of 13.8 years, 979 incident cases of AF occurred. In adjusted models, the concomitant presence of ECG-LAA and albuminuria was associated with a higher risk of AF than either ECG-LAA or albuminuria in isolation (HR (95% CI): 2.43 (1.65-3.58), 1.33 (1.05-1.69), and 1.55 (1.27-1.88), respectively (interaction p-value = 0.50). Effect modification by race was observed with a 4-fold greater AF risk in Black participants with albuminuria + ECG-LAA (HR (95%CI): 4.37 (2.38-8.01) but no significant association in White participants (HR (95% CI) 0.60 (0.19-1.92) respectively; (interaction p-value for race x albuminuria-ECG-LAA combination = 0.05).
Concomitant presence of ECG-LAA and albuminuria confers a higher risk of AF compared to either one in isolation with a stronger association in Blacks than Whites.
本研究旨在探讨白蛋白尿和心电图左心房异常(ECG-LAA)与房颤(AF)事件的联合相关性,并分析这种相关性是否因种族而异。
本分析纳入了无临床心血管疾病(CVD)包括房颤(AF)的 6670 名多民族动脉粥样硬化研究参与者。心电图左心房异常定义为 P 波终末电势在 V1 导联(PTFV1)>5000 μV·ms。白蛋白尿定义为尿白蛋白/肌酐比值(UACR)≥30mg/g。通过医院出院记录和研究计划中的心电图确定 2015 年之前的房颤事件。使用 Cox 比例风险模型分析“无白蛋白尿+无心电图左心房异常(参考)”、“孤立性白蛋白尿”、“孤立性心电图左心房异常”和“白蛋白尿+心电图左心房异常”与房颤事件的相关性。
中位随访 13.8 年后,共发生 979 例房颤事件。在调整后的模型中,与孤立性心电图左心房异常或白蛋白尿相比,同时存在心电图左心房异常和白蛋白尿与房颤风险增加相关(HR(95%CI):2.43(1.65-3.58),1.33(1.05-1.69)和 1.55(1.27-1.88),交互检验 p 值=0.50)。种族存在效应修饰作用,黑种人同时存在白蛋白尿和心电图左心房异常的房颤风险增加 4 倍(HR(95%CI):4.37(2.38-8.01),而白种人无显著相关性(HR(95%CI)0.60(0.19-1.92);种族×白蛋白尿-心电图左心房异常联合作用的交互检验 p 值=0.05)。
与孤立性白蛋白尿或孤立性心电图左心房异常相比,同时存在心电图左心房异常和白蛋白尿与房颤风险增加相关,且在黑种人比白种人中相关性更强。